摘要
目的:评价两种用药方案治疗四肢骨折的临床疗效及经济学意义。方法:采用回顾性研究方法,选择某院外科住院部四肢骨折患者,随机分为A组(鹿瓜多肽组)152例与B组(复方骨肽组)151例,观察其疗效、不良反应,并分析成本-效果。结果:A、B组有效率分别为95.39%、92.72%,药物成本分别为2256.00、1290.60元,成本-效果比分别为2365.03、1391.93,不良反应1例。结论:两种药物治疗四肢骨折疗效均较好,但B组(复方骨肽组)更经济实惠。
Objective： To evaluate the clinical effects and pharmacoeconomic effectiveness of the two drug regimen for the treatment of limb fractures. Methods： A retrospective study of the limb fractures patients （May 1, 2012-May 31, 2013 ） of the In-patient Dept. of Surgery of a hospital. Group A of 152 （ Cervus and Cucumis Polypeptide Group） and Group B of 151 （Compound Ossotide Group） were randomly di- vided to compare the effects, the adverse effects and the cost-effectiveness ratio. Results： The effective rates of the two groups were re- spectively 95. 39% and 92. 72%, the costs RMB2256. 00 and RMB1290. 60, and cost-effectiveness ratios were 2365. 03 and 1391.93. There was 1 untoward effect. Conclusion： Both drugs are effective with Compound Ossotide being more economic.
出处
《亚太传统医药》
2014年第4期129-130,共2页
Asia-Pacific Traditional Medicine
关键词
四肢骨折
药物经济学
鹿瓜多肽
复方骨肽
Limb Fractures
Pharmacoeconomics
Cervus and Cucumis Polypeptide
Compound Ossotide
